MEM OBI

2.4K posts

MEM OBI banner
MEM OBI

MEM OBI

@ObiMem

Grandmaster-Obi Former #Wallstreetbets Moderator & Lead Analyst of Making Easy Money Discord Server $PLTR $SPY $TSLA $NVDA #Stockmarket #finance

New York, New York 参加日 Şubat 2022
0 フォロー中6.8K フォロワー
固定されたツイート
MEM OBI
MEM OBI@ObiMem·
Making Easy Money Discord will close at 25K members. We’re already near 18K and expect to reach capacity in 30 days or less. Once full, new members will not be accepted. 🔒 Join before the cutoff. #StockMarketToday #FinanceNews #GME $GME $AMC discord.gg/YqvzmBgfYW
English
1
0
2
4.2K
Shay Boloor
Shay Boloor@StockSavvyShay·
THE S&P 500 JUST CROSSED 7,100 FOR THE FIRST TIME EVER
Shay Boloor tweet media
English
51
112
1.1K
42.2K
Bull Theory
Bull Theory@BullTheoryio·
NO SAAS COMPANY IS SAFE FROM CLAUDE NOW. Figma is down 12% and Adobe is down 4% after Anthropic launched Claude Design. You can now build prototypes, slides, presentations and one pagers just by talking to Claude. Describe what you want and it builds the first version. It exports directly to Canva, PDF or PowerPoint. Or hand it off to Claude Code when the design is ready to ship. This is powered by Claude Opus 4.7 which launched yesterday. And remember, this is not even their most powerful model. Their best model Mythos is too dangerous to release publicly. Figma's entire business is collaborative design software. Teams paying monthly subscriptions to build prototypes, slides and landing pages that Claude now generates from a single sentence. Three separate AI labs have now launched tools that directly replace what Figma does.
Bull Theory tweet media
English
34
56
378
38.3K
unusual_whales
unusual_whales@unusual_whales·
"The ‘affordability economy’ has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Belt," per FORTUNE
English
96
93
1.5K
153.5K
Mike Investing
Mike Investing@MrMikeInvesting·
Markets have shifted since 2025, & this year large cap names will lead versus smaller caps. Here are 5 “MUST-BUY” large cap stocks, & their targets: 1. $GOOGL will be $430+ 2. $AMZN will be $330+ 3. $TSLA will be $600+ 4. $MSFT will be $500+ 5. $AMD will be $320+ Many will make millions off these names…
Mike Investing tweet mediaMike Investing tweet mediaMike Investing tweet mediaMike Investing tweet media
English
73
142
936
131.2K
Joel
Joel@growthrapidly·
$HIMS 10,000 shares of this stock alone will make you a millionaire when it trades at $100 a share. I strongly believe HIMS can achieve that in the next 24 months.
Joel tweet media
English
56
32
404
57.7K
Jesse Cohen
Jesse Cohen@JesseCohenInv·
Wall Street is pointing to fresh record highs at Thursday's open. The bulls are in control.
Jesse Cohen tweet media
English
26
67
480
24.4K
unusual_whales
unusual_whales@unusual_whales·
There is an 83% chance Trump announces the end of military operations against Iran by June 30, per Polymarket:
unusual_whales tweet media
English
70
33
276
90.1K
Dividend Hero
Dividend Hero@HeroDividend·
Investing is easy Just buy stocks before they do this
Dividend Hero tweet media
English
70
49
1.6K
51.8K
Serenity
Serenity@aleabitoreddit·
This announcement is the most bullish catalyst for $HIMS revenue re-acceleration to date. This is amid: - 30%+ of the float sold short - new $NVO partnership/lawsuit dropped - new global acquisitions - recovering macro climate. The share price is still $25, down from $70 last year. Short sellers are likely in trouble: $HIMS can capture market share at the ~70%-80% gross margins typical of their compounded products for the holy grail of the "Grey Market" TAM for peptides. - EG. Healing: BPC-157 and Thymosin beta-4 - Hair & Skin: GHK-Cu - Weight Loss & Muscle: MOTS-c and Ibutamoren And now they're probably the world's largest independent DTC distribution network to date from their new acquisitions... So just running a peptide protocol subscription between $150 to $300, for 200k subscribers is $360M+ in high-margin ARR. As just one example, but now they have a worldwide net of customers. They burned through capex last year to acquire peptide manufacturing facilities too... so now that's turned into a massive cash-cow business. I said $HIMS would need fundamental changes in order to force shorts to cover, and this is probably that signal as seen with market data. And $HIMS is turning into a fundamentally sound company after regulatory de-risking.
Serenity tweet mediaSerenity tweet media
Secretary Kennedy@SecKennedy

Today, we took long-overdue action to restore science, accountability, and the rule of law. In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk. Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence. • BPC-157 • Thymosin beta-4 fragment (LKKTETQ) • Epitalon • GHK-Cu (injectable) • MOTS-c • DSIP (Emideltide) • Dihexa Acetate • Ibutamoren Mesylate • Melanotan II • KPV • Semax (heptapeptide) • Cathelicidin LL-37 This action begins to restore regulated access and will immediately begin shifting demand away from the black market. We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.

English
93
180
2.1K
735.5K